250 related articles for article (PubMed ID: 22633094)
1. Treating hepatitis C infection by targeting the host.
Salloum S; Tai AW
Transl Res; 2012 Jun; 159(6):421-9. PubMed ID: 22633094
[TBL] [Abstract][Full Text] [Related]
2. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.
Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T
Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218
[TBL] [Abstract][Full Text] [Related]
3. Host cell kinases and the hepatitis C virus life cycle.
Colpitts CC; Lupberger J; Doerig C; Baumert TF
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1657-62. PubMed ID: 25896387
[TBL] [Abstract][Full Text] [Related]
4. Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.
von Hahn T; Ciesek S; Manns MP
Discov Med; 2011 Sep; 12(64):237-44. PubMed ID: 21955851
[TBL] [Abstract][Full Text] [Related]
5. New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets.
Ploss A; Dubuisson J
Gut; 2012 May; 61 Suppl 1():i25-35. PubMed ID: 22504917
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
7. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
Bukh J
J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
[TBL] [Abstract][Full Text] [Related]
8. High-throughput approaches to unravel hepatitis C virus-host interactions.
Colpitts CC; El-Saghire H; Pochet N; Schuster C; Baumert TF
Virus Res; 2016 Jun; 218():18-24. PubMed ID: 26410623
[TBL] [Abstract][Full Text] [Related]
9. Targets for antiviral therapy of hepatitis C.
Rupp D; Bartenschlager R
Semin Liver Dis; 2014 Feb; 34(1):9-21. PubMed ID: 24782254
[TBL] [Abstract][Full Text] [Related]
10. A Cell Culture Model for Persistent HCV Infection.
Castro V; Ávila-Pérez G; Mingorance L; Gastaminza P
Methods Mol Biol; 2019; 1911():157-168. PubMed ID: 30593624
[TBL] [Abstract][Full Text] [Related]
11. Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection.
Zeisel MB; Crouchet E; Baumert TF; Schuster C
Viruses; 2015 Nov; 7(11):5659-85. PubMed ID: 26540069
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.
Colpitts CC; Baumert TF
Hepatol Int; 2016 Sep; 10(5):741-8. PubMed ID: 27048616
[TBL] [Abstract][Full Text] [Related]
14. The science of direct-acting antiviral and host-targeted agent therapy.
Pawlotsky JM
Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
[TBL] [Abstract][Full Text] [Related]
15. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
16. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in the development of chronic hepatitis C as potential targets of antiviral therapy.
Jackowiak P; Figlerowicz M; Kurzyńska-Kokorniak A; Figlerowicz M
Curr Pharm Biotechnol; 2011 Nov; 12(11):1774-80. PubMed ID: 21902631
[TBL] [Abstract][Full Text] [Related]
18. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.
Georgel P; Schuster C; Zeisel MB; Stoll-Keller F; Berg T; Bahram S; Baumert TF
Trends Mol Med; 2010 Jun; 16(6):277-86. PubMed ID: 20537953
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and natural compounds: a new antiviral approach?
Calland N; Dubuisson J; Rouillé Y; Séron K
Viruses; 2012 Oct; 4(10):2197-217. PubMed ID: 23202460
[TBL] [Abstract][Full Text] [Related]
20. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
